Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00124904 · ClinicalTrials.gov registry record · NA
Biofeedback for Fecal Incontinence
A NA study, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- NA
- Development phase
- 165
- Enrollment target
NCT00124904 is a NA study that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 165 participants.
The verdict
NCT00124904, a NA study, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- NA
- Development phase
- 165 participants
- Enrollment target
Study Summary
Fecal incontinence affects 2% of adults in the United States. Biofeedback has been recommended for the treatment of fecal incontinence because uncontrolled studies over the past 25 years suggest that these treatments are as effective as medical or surgical management and involve no risk. However, placebo-controlled trials are still lacking. The aims of this study are: (1) to compare biofeedback to alternative therapies for which patients have a similar expectation of benefit; (2) to identify which patients are most likely to benefit; and (3) to assess the impact of treatment on quality of life.
Interventions
- BEHAVIORAL Biofeedback
- BEHAVIORAL Kegel exercises
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 1999-09 |
| Est. Completion | 2006-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00124904
The ClinicalTrials.gov registry entry for NCT00124904 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Biofeedback is the first listed.
NCT00124904 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00124904 about?
NCT00124904 is a clinical study titled "Biofeedback for Fecal Incontinence". Fecal incontinence affects 2% of adults in the United States. Biofeedback has been recommended for the treatment of fecal incontinence because uncontrolled studies over the past 25 years suggest that these treatments are as effective as medical or surgical management and involve no risk. However, pl...
What is the current status of trial NCT00124904?
This trial is currently completed. It is a NA study. The enrollment target is 165 participants. The study started on 1999-09. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00124904?
The interventions under investigation include: Biofeedback (BEHAVIORAL), Kegel exercises (BEHAVIORAL).
Who is sponsoring clinical trial NCT00124904?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.